Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? - Wikidata - wikimedia - TriplyDB

Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

http://www.wikidata.org/entity/Q38763935

about

Is surgery still the optimal treatment for stage I non-small cell lung cancer?Stereotactic radiosurgery for small brain metastases and implications regarding management with systemic therapy alone.Hypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage I non-small-cell lung cancer.Trial Watch: Immunotherapy plus radiation therapy for oncological indications.Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma.Mitotic catastrophe is a putative mechanism underlying the weak correlation between sensitivity to carbon ions and cisplatin.Plasma levels of soluble programmed death ligand-1 may be associated with overall survival in nonsmall cell lung cancer patients receiving thoracic radiotherapy.Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors.Cancer-associated Fibroblasts Promote Irradiated Cancer Cell Recovery Through Autophagy.Optimizing tumor immune response through combination of radiation and immunotherapy.Combining radiotherapy with immunotherapy: the past, the present and the future.A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer.Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells.7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.Stereotactic body radiotherapy in the era of radiotherapy with immunotherapy.Radiotherapy Dosing for Locally Advanced Non-Small Cell Lung Carcinoma: "MTD" or "ALARA"?Abscopal effect in recurrent colorectal cancer treated with carbon-ion radiation therapy: 2 case reports.Radiation generates an abscopal response and complete resolution of metastatic squamous cell carcinoma of the anal canal: a case report.Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience.Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis.Thyroid autoimmune antibodies in patients with papillary thyroid carcinoma: a double-edged sword?Breathing New Life Into Hypoxia-Targeted Therapies for Non-Small Cell Lung Cancer.Can radiotherapy potentiate the effectiveness of immune checkpoint inhibitors in lung cancer?Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.Using immunotherapy to boost the abscopal effect.Improving immune-vascular crosstalk for cancer immunotherapy.Radiation therapy and immunotherapy: what is the optimal timing or sequencing?Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.A rapid and systemic complete response to stereotactic body radiation therapy and pembrolizumab in a patient with metastatic renal cell carcinoma.Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study.Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment.Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer.Combining radiation plus immunotherapy to improve systemic immune response.Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway.Postoperative Cavity Stereotactic Radiosurgery for Brain Metastases Role of noninvasive molecular imaging in determining response SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases

P2860

Q26749371-AE64F7CE-8ADD-44FA-A64A-B61990743E49 Q30252216-FD019C22-13CA-442D-9B0C-922F59C42F09 Q33884923-A055320D-9A96-45F3-92F6-E2D9F8AF6C7D Q37308207-3596CD53-0C86-44DC-9C2E-45B635E7E758 Q37566921-55E6E303-E5DE-403A-8E12-CDCE400E13BF Q37587579-08CEEB48-4B9E-40B3-A7E1-46D0B2FA2F45 Q37656305-34486D41-22CA-43C5-AE1E-1112C2B2DCBF Q37685388-2AAF879B-0087-42F5-9413-F81EA1BA1F8D Q37714296-3C174303-3FB6-47C5-BE56-5AECACBBE567 Q38614781-4E30177E-9527-4E0B-8FF2-7EEFFCFA3BDC Q38679418-88EC20A7-A27E-4FCF-B800-18A6D6E52596 Q38790915-43E947A5-A781-4136-829E-856CE9CE79DC Q38990272-C908B67F-75E3-4A4C-8990-1597155E5BFB Q39370246-1CAD55E3-BD5D-4EF4-B41B-BF6A878BAFAB Q40271942-2A2AC1FD-8116-49EE-82A1-21641726B04D Q41092061-B2314C7E-0A70-4B28-9B02-22BEC823EAA0 Q42344264-7F76FE1C-FA33-471C-8CE6-47323B41B624 Q42363788-CE773576-2975-4758-805E-E1BAA150F634 Q43379642-26B15226-CE0A-4D0A-902B-E696D6D3A7D5 Q47098450-B230A7F7-1540-494B-9CE6-B261BC2156F3 Q47108053-957EE34B-25A3-4EF6-9DE6-4DFC1376DB17 Q47163615-6EE7FACA-CA43-46FB-846E-DBDF09736EC5 Q47647111-098A2F22-A860-4C56-A199-96FBF9A42191 Q47769984-6FD3D569-DDB5-4CF1-BFFD-74720F2E4865 Q47821832-81ADBE33-8799-4584-9122-1B3FF305A2BE Q48193685-4A82E5E3-2988-4121-B74A-95B779F3EF5F Q49666975-953A218A-9BE7-4872-A461-FFDB91097E7A Q49958115-4F6B7436-7410-4B47-9039-B3F7617DFEA1 Q50051034-1004163E-7703-48DB-A5EC-30D48081746D Q50109474-7ABB7C68-F28E-4D4A-BF40-3B45354A9209 Q50862063-95DD7574-8F5F-43F1-8014-8F6823185E1C Q53186440-50893D5E-008B-4347-BD29-2473611284E7 Q54974804-2EF26A2F-0865-442F-9494-7958BF3D38C0 Q55010484-B1F039B8-A909-48B8-ABCC-119AE8564573 Q55129503-5A3AF86F-8868-4764-92A7-3DAF4C2D59E7 Q55235684-9F2D2168-DC1D-4ECC-B2E4-E11B3765B020 Q55294642-CD3D63FA-E1F3-42E9-90E2-7766F05CB9C2 Q57166492-560DD7C0-C2A7-4E8E-9FFE-0824F026147F Q58119177-1D0AE64C-301E-4612-B428-FEBD109BF1E6 Q58743563-FC4D27F3-00A5-439A-ABBA-D951476AA5BB

P2860

Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

http://www.wikidata.org/entity/Q38763935

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

@en

type

label

Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

@en

prefLabel

Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

@en

P1433

Q38763935-29FD69FE-446A-44AF-8130-92421D0CD0E5

P1476

Q38763935-37A3DB9E-D1B1-401C-971C-F288646832A6

P2093

Q38763935-068743A4-A441-4154-8351-31D704C53AA0

Q38763935-1C38754A-42DB-4341-A971-461C9735C918

Q38763935-8146769C-D762-479E-9B23-06E309B13068

Q38763935-B29739DF-56E4-446F-A289-4395591AB366

P2860

Q38763935-066C111B-D157-46DF-A3A9-EAF8D41F060E

Q38763935-07D28F53-E5A5-477F-A454-8DBA9986FD4F

Q38763935-0AAC25E5-6CAA-4795-B729-44CB3CEE3471

Q38763935-0E77A8B1-2BCE-41EC-A86B-DAD0B4F79D05

Q38763935-0EA0B41B-DFBE-4AA5-AECD-4D0A06E0593B

Q38763935-13FCA613-FC91-450B-98F3-48CB7898CCDF

Q38763935-140291C7-7392-4AE6-A4A7-67C1C625F801

Q38763935-21AB428D-5364-4666-BB39-7DCFE8D88830

Q38763935-22C2A11C-902A-42BD-BF99-9A637E5A10FA

Q38763935-242F1D4B-E095-482B-9780-617783D636E2

P2888

Q38763935-B6667BA2-F7BC-41FE-AD0C-C56D4D8E3C95

P304

Q38763935-F8562141-85AD-4705-B320-64FBD61DDA7F

P31

Q38763935-BE77F735-CF23-4328-A5D5-79CF69D45F34

P356

Q38763935-62C30B9C-1613-48CC-A526-93869553DCE5

P407

Q38763935-E8222A60-9913-48A5-B192-F27B3043ED7B

P433

Q38763935-3C9DAE7C-CAAB-442C-B164-45CA4ACDAA37

P478

Q38763935-FC87D12B-83DB-43FB-9919-7FB06D80184F

P577

Q38763935-3EB15C03-0338-4B0A-BB0C-E9AE8E23EF3F

P6179

Q38763935-014A78DD-6815-465E-9C8B-51249C698609

P698

Q38763935-D03A8801-0FCB-493D-8056-B85DC80B7471

P921

Q38763935-C0CB06F5-CABC-4B29-A9AF-68391A920829

P932

Q38763935-FDAF7473-C05C-4621-86DB-B2FDCFF3A9FA

P356

NRCLINONC.2016.30

P1433

Nature Reviews Clinical Oncology

P1476

Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

@en

P2093

James W Hodge

http://www.w3.org/2001/XMLSchema#string

Joe Y Chang

http://www.w3.org/2001/XMLSchema#string

Michael B Bernstein

http://www.w3.org/2001/XMLSchema#string

Sunil Krishnan

http://www.w3.org/2001/XMLSchema#string

P2860

Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection

Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses

Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice

The blockade of immune checkpoints in cancer immunotherapy

An in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapy

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Immunologic correlates of the abscopal effect in a patient with melanoma

Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting

P2888

nrclinonc.2016.30

P304

516-524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCLINONC.2016.30

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029170434

http://www.w3.org/2001/XMLSchema#string

P698

26951040

http://www.w3.org/2001/XMLSchema#string

P921

P932

6053911

http://www.w3.org/2001/XMLSchema#string